These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9568820)

  • 1. High frequency of iron bone deposits in a Mexican population with renal osteodystrophy.
    Velásquez Forero F; Altamirano E; Ramos PT
    Nephrol Dial Transplant; 1998; 13 Suppl 3():46-50. PubMed ID: 9568820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA; Libbey NP; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron overload and bone disease in chronic dialysis patients.
    Van de Vyver FL; Visser WJ; D'Haese PC; De Broe ME
    Nephrol Dial Transplant; 1990; 5(9):781-7. PubMed ID: 2129351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum aluminum levels as a reflection of renal osteodystrophy status and bone surface aluminum staining.
    Hodsman AB; Steer BM
    J Am Soc Nephrol; 1992 Feb; 2(8):1318-27. PubMed ID: 1378308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal osteodystrophy in pre-dialysis patients: ethnic difference?
    Shin SK; Kim DH; Kim HS; Shin KT; Ma KA; Kim SJ; Kwak YS; Ha SK; Sherrard DJ
    Perit Dial Int; 1999; 19 Suppl 2():S402-7. PubMed ID: 10406554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study using nondecalcified bone biopsy of the incidence and presentation forms of renal osteodystrophy].
    Lorenzo Sellares V; Torres Ramírez A; Hernández Marrero D; Rodríguez Pérez J; González Posada J; Losada Cabrera M; Maceira Cruz B; Hernández Nieto L
    Med Clin (Barc); 1991 Apr; 96(15):561-5. PubMed ID: 2051811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low turnover bone disease is the more common form of bone disease in CAPD patients.
    Rodriguez-Perez JC; Plaza C; Torres A; Vega N; Anabitarte A; Fernandez A; Lorenzo V; Hortal L; Palop L
    Adv Perit Dial; 1992; 8():376-80. PubMed ID: 1361827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2000; 20(4):362-72. PubMed ID: 11039262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.
    Coen G; Ballanti P; Bonucci E; Calabria S; Centorrino M; Fassino V; Manni M; Mantella D; Mazzaferro S; Napoletano I; Sardella D; Taggi F
    Nephrol Dial Transplant; 1998 Sep; 13(9):2294-302. PubMed ID: 9761512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relevance of mineralization lag time in the evaluation of histologic changes in renal osteodystrophy.
    Libbey NP; Chazan JA; London MR; Pono L; Abuelo JG
    Clin Nephrol; 1993 Apr; 39(4):214-23. PubMed ID: 8491052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients--retrospective analysis of 1429 iliac crest biopsies.
    Ballanti P; Wedard BM; Bonucci E
    Nephrol Dial Transplant; 1996 Apr; 11(4):663-7. PubMed ID: 8671855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis.
    Hernandez D; Concepcion MT; Lorenzo V; Martinez ME; Rodriguez A; De Bonis E; Gonzalez-Posada JM; Felsenfeld AJ; Rodriguez M; Torres A
    Nephrol Dial Transplant; 1994; 9(5):517-23. PubMed ID: 7522307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis.
    Gerakis A; Hutchison AJ; Apostolou T; Freemont AJ; Billis A
    Nephrol Dial Transplant; 1996 Dec; 11(12):2430-8. PubMed ID: 9017618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophy.
    Ng AH; Hercz G; Kandel R; Grynpas MD
    Bone; 2004 Jan; 34(1):216-24. PubMed ID: 14751580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal osteodystrophy in Maracaibo].
    Salgado O; García R; Delling G; Navarro J; Romero RA; Rodríguez-Iturbe B
    Invest Clin; 1992; 33(4):153-64. PubMed ID: 1303675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone aluminum deposition in maintenance dialysis patients treated with aluminium-free dialysate: role of aluminium hydroxide consumption.
    Heaf JG; Pødenphant J; Andersen JR
    Nephron; 1986; 42(3):210-6. PubMed ID: 3945361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated bone aluminum and suppressed parathyroid hormone levels in hypercalcemic dialysis patients.
    Piraino B; Chen T; Puschett JB
    Am J Nephrol; 1989; 9(3):190-7. PubMed ID: 2757078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renal osteodystrophy: aluminium and secondary hyperparathyroidism].
    de Vernejoul MC
    Rev Prat; 1990 Mar; 40(7):613-8. PubMed ID: 2326587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of bone aluminum content and bone histology in patients on chronic hemodialysis and hemofiltration.
    Sebert JL; Fournier A; Leflon P; Fohrer P; de Frémont JF; Morinière P; Galy C; Marie A; Demontis R; Boudailliez B
    Nephron; 1986; 42(1):34-40. PubMed ID: 3941748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.